clonazepam has been researched along with 2019 Novel Coronavirus Disease in 10 studies
Clonazepam: An anticonvulsant used for several types of seizures, including myotonic or atonic seizures, photosensitive epilepsy, and absence seizures, although tolerance may develop. It is seldom effective in generalized tonic-clonic or partial seizures. The mechanism of action appears to involve the enhancement of GAMMA-AMINOBUTYRIC ACID receptor responses.
clonazepam : 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. However, its use can be limited by the development of tolerance and by sedation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Neither diazepam nor other ligands for benzodiazepine binding sites protect against or attenuate chloroquine cardiotoxicity." | 3.96 | Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam. ( Hughes, DA, 2020) |
| "Since the emergence of coronavirus disease 2019 (COVID-19), neurological symptoms, syndromes, and complications associated with this multi-organ viral infection have been reported and the various aspects of neurological involvement are increasingly uncovered." | 2.72 | Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature. ( Aghavali, S; Babadi, M; Daraie, P; Emamikhah, M; Jalili, M; Mehrabani, M; Mohaghegh, F; Pouranian, M; Rohani, M; Zaribafian, M, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 10 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nelson, JL | 1 |
| Blume, GM | 1 |
| Bansal, SK | 1 |
| Kaufman, JR | 1 |
| Woods, FR | 1 |
| Zhang, X | 1 |
| Kattah, JC | 1 |
| Adhikari, S | 1 |
| Kumar, R | 1 |
| Driver, EM | 1 |
| Bowes, DA | 1 |
| Ng, KT | 1 |
| Sosa-Hernandez, JE | 1 |
| Oyervides-Muñoz, MA | 1 |
| Melchor-Martínez, EM | 1 |
| Martínez-Ruiz, M | 1 |
| Coronado-Apodaca, KG | 1 |
| Smith, T | 1 |
| Bhatnagar, A | 1 |
| Piper, BJ | 1 |
| McCall, KL | 1 |
| Parra-Saldivar, R | 1 |
| Barron, LP | 1 |
| Halden, RU | 1 |
| Bhatia, MS | 1 |
| Goyal, S | 1 |
| Singh, A | 1 |
| Daral, A | 1 |
| Hughes, DA | 1 |
| Mawhinney, JA | 1 |
| Wilcock, C | 1 |
| Haboubi, H | 1 |
| Roshanzamir, S | 1 |
| Uvais, NA | 1 |
| Lohiya, N | 2 |
| Karve, S | 1 |
| Agarkhedkar, S | 1 |
| Emamikhah, M | 1 |
| Babadi, M | 1 |
| Mehrabani, M | 1 |
| Jalili, M | 1 |
| Pouranian, M | 1 |
| Daraie, P | 1 |
| Mohaghegh, F | 1 |
| Aghavali, S | 1 |
| Zaribafian, M | 1 |
| Rohani, M | 1 |
| Totomoch-Serra, A | 1 |
| Ibarra-Miramon, CB | 1 |
| Manterola, C | 1 |
| Urrea-Mendoza, E | 1 |
| Okafor, K | 1 |
| Ravindran, S | 1 |
| Absher, J | 1 |
| Chaubal, V | 1 |
| Revilla, FJ | 1 |
1 review available for clonazepam and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature.
Topics: Adult; Anticonvulsants; Ataxia; Azithromycin; Clonazepam; Cough; COVID-19; COVID-19 Drug Treatment; | 2021 |
9 other studies available for clonazepam and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Postinfectious SARS-CoV-2 Opsoclonus-Myoclonus-Ataxia Syndrome.
Topics: Cerebellar Ataxia; Clonazepam; COVID-19; Female; Humans; Immunoglobulin G; Methylprednisolone Hemisu | 2022 |
Occurrence of Z-drugs, benzodiazepines, and ketamine in wastewater in the United States and Mexico during the Covid-19 pandemic.
Topics: Alprazolam; Benzodiazepines; Clonazepam; COVID-19; Diazepam; Humans; Ketamine; Lorazepam; Mexico; No | 2023 |
COVID-19 Pandemic-Induced Panic Disorder.
Topics: Adult; Betacoronavirus; Clonazepam; Coronavirus Infections; COVID-19; Humans; Male; Pandemics; Panic | 2020 |
Acute chloroquine poisoning: A comprehensive experimental toxicology assessment of the role of diazepam.
Topics: Animals; Arrhythmias, Cardiac; Benzodiazepinones; Cardiotoxicity; Chloroquine; Clonazepam; Coronavir | 2020 |
Neurotropism of SARS-CoV-2: COVID-19 presenting with an acute manic episode.
Topics: Adult; Affective Symptoms; Betacoronavirus; Cerebrospinal Fluid; Clonazepam; Coronavirus Infections; | 2020 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Ci | 2020 |
A Tale of COVID-19: Beyond Physical Ailment.
Topics: Anxiety; Anxiety Disorders; Child; Clonazepam; Cognitive Behavioral Therapy; COVID-19; Diagnosis, Di | 2021 |
Persistent Hiccups as Main COVID-19 Symptom.
Topics: Cholesterol; Clonazepam; Comorbidity; COVID-19; COVID-19 Drug Treatment; Haloperidol; Hernia, Umbili | 2021 |
Opsoclonus-Myoclonus-Ataxia Syndrome (OMAS) Associated with SARS-CoV-2 Infection: Post-Infectious Neurological Complication with Benign Prognosis.
Topics: Adult; Clonazepam; COVID-19; GABA Agents; Humans; Male; Methylprednisolone; Neuroprotective Agents; | 2021 |